Dr. Lewis presents today’s Morning Report!
Hypoglycemia
Hypoglycemia: serum glucose of <50 mg/dL, less than 30 mg/dL is considered severe hypoglycemia
Causes
Re Renal
Ex Exogenous Insulin/antihyperglycemics
P Pituitary Insufficiency
L Liver
A Alcohol, Addison’s, Aspirin
I Infection, Insulinoma
N Neoplasm
D Drugs
Medications
Sulfonylureas (glipizide/glyburide): ↑insulin secretion and activity, half-life of most is 14-16 hrs
Meglitinides(prandin/starlix): shorter half-life, risk of recurrent hypoglycemia is unknown
Biguanides(metformin)→ enhance effect of insulin without increasing secretion
Symptoms
- Early: Catecholamine release → Adrenergic = tachycardia, irritability, diaphoresis, paresthesias
- More severe or prolonged hypoglycemia → Neuroglycopenia → ms changes including confusion or bizarre behavior, lethargy, or coma, focal neurologic deficits
Management
IV Glucose
- Adults: 0.5 to 1 g/kg, 1 amp of D₅₀ = 50 cc of 50% dextrose in water = contains 25 g of glucose = 100 calories, lasts 15-30 mins, after 30 mins feed or D₁₀W
- Child: D₂₅ 2 cc/kg, Neonate: D₁₀ 2-4 cc/kg
- Caution: pts that can produce insulin via glucose-stimulated insulin release (nondiabetics or type 2 DM) repeated dextrose →recurrent hypoglycemia
- 1 L D5W at 100mL/hr = 20 cal/hr (5 skittles/hr), 1 L D10W at 100mL/hr = 40 cal/hr (10 skittles/hr)
Glucagon
- Stimulates cAMP →promotes hepatic glycogenolysis and gluconeogenesis
- 1 mg subq or IM repeated q20 mins, requires ≥15 mins for onset of action, associated with vomiting
- may be ineffective in pts with depleted glycogen stores, stimulates insulin release from the pancreas → prolonged hypoglycemia in settings such as sulfonylurea ingestion and insulinoma
Octreotide
- Synthetic somatostatin = inhibit glucose-stimulated β cell insulin release, half-life of 72 minutes, duration 6-12 hrs, peaks at 20 mins
- Sulfonylurea-induced hypoglycemia
- IV/subq suggested dose is subq 50-100 µg q6hrs, IV 100-125 µg/hr after 2nd episode of hypoglycemia
- Fewer episodes of recurrent hypoglycemia
Special consideration
- Pts with sulfonylurea/meglitinide related hypoglycemia after initial control with D₅₀→ feeding or octreotide, routine dextrose infusion should be avoided b/c it causes glucose stimulated insulin release
Disposition
- Diabetic on therapeutic doses of insulin with hypoglycemia after missed meal /metformin→ d/c after 4-6 hr observation
- All hypoglycemia related to sulfonylurea use/lantus → admit
References
Goldfrank’s Toxicologic Emergencies, 10eRobert S. Hoffman, Mary Ann Howland, Neal A. Lewin, Lewis S. Nelson, Lewis R. Goldfrank
Jay Khadpe MD
- Editor in Chief of "The Original Kings of County"
- Assistant Professor of Emergency Medicine
- Assistant Residency Director
- SUNY Downstate / Kings County Hospital
Latest posts by Jay Khadpe MD (see all)
- Save of the Month! December 2015 - December 23, 2015
- Morning Report: Unprovoked First Seizure in Adults - September 11, 2015
- Morning Report: Extramural Deliveries in the Emergency Room - September 10, 2015
1 Comment
Ian deSouza · February 5, 2015 at 1:46 pm
Severe hyoglycemia (can be considered an “H” in the “Hs/Ts”) resulting in neuroglycopenia MAY lead to PEA arrest. It not a typical cause of cardiac arrest and it not often described in the literature, but I have seen one case where hypoglycemia was a likely culprit, only discovered after a post-intubation/resuscitation blood gas…..